Your browser doesn't support javascript.
loading
Infectivity and stability of hepatitis C virus in different perfusion solutions.
Helfritz, Fabian A; Wanders, Verena; Bojkova, Denisa; Kuklinski, Nina; Westhaus, Sandra; Swoboda, Sandra; Minor, Thomas; Meuleman, Philip; Paul, Andreas; Steinmann, Eike; Ciesek, Sandra.
Afiliação
  • Helfritz FA; General, Visceral and Transplantation Surgery, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Wanders V; Institute of Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Bojkova D; Institute of Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Kuklinski N; Institute of Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Westhaus S; Institute of Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Swoboda S; General, Visceral and Transplantation Surgery, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Minor T; General, Visceral and Transplantation Surgery, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Meuleman P; Department of Clinical Chemistry, Microbiology and Immunology, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
  • Paul A; General, Visceral and Transplantation Surgery, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Steinmann E; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.
  • Ciesek S; Institute of Experimental Virology, Twincore, Centre for Experimental and Clinical Infection Research, Hannover, Germany.
Transpl Infect Dis ; 21(5): e13135, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31246353
ABSTRACT

BACKGROUND:

Owing to organ shortage, transplantation of organs from HCV (hepatitis C virus) viremic donors into HCV negative individuals is getting more and more accepted. However, transmission of HCV to the host is nearly universal. Until now it is unknown if preservation solutions (PS) might alter infectivity and stability of HCV in the transplant setting. Therefore, seven different preservation solutions (PS) with variable composition were tested in vitro for their direct anti- and proviral effects on HCV.

METHODS:

In vitro grown HCV based on the JFH-1 isolate was used to characterize the effect of seven different PS on the HCV replication cycle including HCV attachment, entry, replication, and assembly. In addition, HCV stability in PS was tested.

RESULTS:

Overall, 6/7 PS enhanced HCV infectivity IGL-1 increased HCV attachment and entry, UW Belzer and Perfadex boosted HCV entry. Production of novel viral particles was enhanced in HTK, UW Belzer, and IGL-1. In contrast, viral replication was significantly reduced in HTK solution while all other PS had no effect on HCV RNA replication. HCV was significantly more stable in HTK solution. Euro Collins was the only PS that did not support HCV infectivity in cell culture. None of the used PS showed cytotoxic effects.

CONCLUSION:

Our data indicate that HCV infectivity and stability is maintained by several PS.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Replicação Viral / Hepacivirus / Soluções para Preservação de Órgãos Limite: Humans Idioma: En Revista: Transpl Infect Dis Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Replicação Viral / Hepacivirus / Soluções para Preservação de Órgãos Limite: Humans Idioma: En Revista: Transpl Infect Dis Ano de publicação: 2019 Tipo de documento: Article